Pharmaceutical executives spend billions building patent portfolios. Analysts spend months modeling their worth. And yet the conversation about what actually
Drug Patent Value: The Indicators That Actually Predict Pharma Market Power Read Post »
A drug patent is not a legal formality. It is the financial architecture that determines whether a company can fund
1. The Problem: Eroom’s Law and the Monolith Trap The Economics Are Getting Worse, Not Better Drug development has gotten
Snackable AI in Pharma: The Modular Architecture That Beats Eroom’s Law Read Post »
1. The Effective Patent Life Problem: Numbers, Not Theory Here is what the 20-year patent term looks like from inside
Key Takeaways (Executive Summary) Part I: What Drug Repurposing Actually Is — and Why the Economics Changed Defining the Strategy:
Sign in or create a free account to read this DrugPatentWatch article
